Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas
about
American Cancer Society Head and Neck Cancer Survivorship Care GuidelineSquamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterizationThe Tip of the Iceberg: Clinical Implications of Genomic Sequencing Projects in Head and Neck CancerDDX3, a potential target for cancer treatmentProfiling invasiveness in head and neck cancer: recent contributions of genomic and transcriptomic approachesGenomic landscape of human papillomavirus-associated cancersTherapeutic insights from genomic studies of head and neck squamous cell carcinomasFGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell CancersDecreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical applicationTRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinomaMoving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic OpportunitiesImmunotherapy in head and neck cancer: aiming at EXTREME precision.Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3.Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.Novel targets in head and neck cancer: should we be optimistic?Genomic analysis of metastatic cutaneous squamous cell carcinoma.Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features.HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.Drug-induced RAF dimerization is independent of RAS mutation status and does not lead to universal MEK dependence for cell survival in head and neck cancersGenomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.Notch1 Activation or Loss Promotes HPV-Induced Oral Tumorigenesis.Genetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors.Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinomaGenetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.Autoinhibitory Interdomain Interactions and Subfamily-specific Extensions Redefine the Catalytic Core of the Human DEAD-box Protein DDX3.Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.Role of several histone lysine methyltransferases in tumor development.Analog sensitive chemical inhibition of the DEAD-box protein DDX3Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low-risk patient as defined by targeted sequencing.Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patientsFGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell CarcinomaPD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma.Hypopharyngeal cancer: looking back, moving forwardGenetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine.Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
P2860
Q26752802-38A696C4-2728-44D5-83F9-DF0875359066Q26765060-5D49AE6C-8A13-4D9A-94B5-39A79F739CDCQ26778433-DE0C255F-2A99-4328-81CA-53163AD3FA7CQ26779054-6A25089C-77BE-4C6D-A137-885AA66C4331Q26995360-C1C3202A-9B0B-4630-A1FB-0A7ED70F1CB4Q26997399-02A0C5B5-BDB2-4E55-8D0D-0CCD9DF57A7EQ27006854-7861A487-0E42-466F-848F-4129A5851C30Q27853171-87262A76-1E64-4C04-AD4A-260E6702499DQ27853173-F134D7AF-D851-4B8E-AF43-C43A9C4F5DA8Q27853178-DF0CC406-D867-45C9-8F0C-C06DEAD4B752Q27853245-69DCEB70-6A34-46FB-869D-E73211E42CE5Q28079309-32B1D8C8-B972-4D4E-9715-BEB406C9923AQ30491128-F4B3C4E6-E6F0-4DB3-8810-D4FE91BAB32FQ31043365-4651ECB6-DBBD-496D-AA6E-6791F36F836DQ33588151-2C256A03-B53C-44A6-BDDC-FB0897F81ED4Q33756244-34A2F825-9850-42FC-ABF7-2A2424574E7AQ33798848-44DCA3AD-D8EF-47AA-B074-136E917FD687Q33814851-788503BA-9970-4069-B263-3601904A1EC2Q35048213-22F445FA-C40F-4090-AF38-5725A9757528Q35178368-7C1FEC69-FA5B-4D06-B832-0BCD7551CCFBQ35251799-9F733CAE-54E3-43EF-B968-3835B945957CQ35762184-27738A15-8FC5-426A-BF3E-75DED61AC91FQ35889525-FE195A2C-6C60-4E5F-A95F-2012A3B32AA6Q35892011-61116F45-3B07-4090-A41B-718EF60AB14CQ36070536-6153132B-E464-45EA-B55D-758751CA9B40Q36100833-8CB429DC-0E44-4D51-9B1C-B02F7FDE035AQ36201478-00677EAF-94CC-48B9-8D06-8E0B0D8CF1C0Q36430737-2C8B1B7A-7CAB-4FCF-83C3-C6CA2E49490EQ36518348-5C706C72-7074-41B8-9F17-8F1A1B0AF7D2Q36528389-B87C4575-4C2F-45B0-90AB-A297C11AC1A3Q36639797-E7EC154A-7718-4F88-945B-4E8AD3E7D5C9Q36749699-55B3E930-6305-46F6-AE00-F52685748983Q36823719-C4791D9E-BCE2-49A6-B7E2-B3A8FD56C49FQ36834857-25DDFCD7-3893-4FAC-A2D9-1DF15C820BD6Q36879739-034BB011-3134-4C43-8784-E06AC642DFDCQ37067161-8CA6A23B-E98A-4CC1-9B66-78E12B79517AQ37085912-299346A4-1FBA-46B8-B1EE-7E409EC32149Q37152875-DE7C0822-3CB1-411A-AA55-AFAE8441D3D4Q37164556-C479ADCE-508D-4F74-9BF4-80F9480C17A7Q37304652-A239B529-A7C8-4992-93F9-1AC3D455BB03
P2860
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Integrative and comparative ge ...... neck squamous cell carcinomas
@ast
Integrative and comparative ge ...... neck squamous cell carcinomas
@en
type
label
Integrative and comparative ge ...... neck squamous cell carcinomas
@ast
Integrative and comparative ge ...... neck squamous cell carcinomas
@en
prefLabel
Integrative and comparative ge ...... neck squamous cell carcinomas
@ast
Integrative and comparative ge ...... neck squamous cell carcinomas
@en
P2093
P2860
P50
P1476
Integrative and comparative ge ...... neck squamous cell carcinomas
@en
P2093
Alexander Langerman
Arun Khattri
Chandra S Pedamallu
Christopher Brown
Elizabeth Blair
Ezra E W Cohen
Johannes Brägelmann
Kerstin Stenson
Kevin P White
P2860
P304
P356
10.1158/1078-0432.CCR-13-3310
P407
P577
2014-07-23T00:00:00Z